NCT01000597 Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects Status COMPLETED Phase PHASE1
NCT01000506 Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma Status COMPLETED Phase PHASE2
NCT01000493 Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder Status COMPLETED Phase PHASE2
NCT01000324 Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult Status COMPLETED Phase PHASE4
NCT00999804 Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00997620 Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis Status COMPLETED Phase PHASE4
NCT00996996 Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00996944 Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) Status TERMINATED Phase PHASE2
NCT00996853 Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom Status COMPLETED Phase N/A
NCT00996840 SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS Status COMPLETED Phase PHASE2
NCT00996762 A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib Status COMPLETED Phase PHASE1
NCT00996671 Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00996593 Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab Status COMPLETED Phase PHASE2
NCT00996268 An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836. Status COMPLETED Phase PHASE1
NCT00996216 Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 Status COMPLETED Phase PHASE3
NCT00996125 Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects Status COMPLETED Phase PHASE3
NCT00995995 Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK Status COMPLETED Phase N/A
NCT00992992 Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2